miR-409-3p在NOD糖尿病小鼠血浆及胰岛免疫浸润中降低,且在1型糖尿病患者中差异表达
该研究分析NOD小鼠和1型糖尿病患者循环miRNA谱,发现糖尿病小鼠血浆5种miRNA下调,其中miR-409-3p在胰岛免疫浸润中也下调,与胰岛炎严重程度相关,且在糖尿病进展中逐渐降低、抗CD3治疗后回升;1型糖尿病患者血浆miR-409-3p低于对照,与HbA1c负相关。
要点
- miR-409-3p在糖尿病NOD小鼠血浆和胰岛免疫浸润中均下调
- miR-409-3p表达与胰岛炎严重程度相关,CD8+中枢记忆T细胞中富集
- 1型糖尿病患者血浆miR-409-3p降低且与HbA1c负相关
核心结论
- miR-409-3p可能成为反映胰岛炎症和1型糖尿病严重程度的新型循环生物标志物。
研究设计与样本
- 采用标准化方法从小样本量血浆和激光捕获显微切割的免疫浸润胰岛中提取miRNA,在近期糖尿病和正常血糖NOD小鼠中评估成熟miRNA谱。
- 在NOD小鼠疾病进展及抗CD3治疗缓解后验证发现,并在1型糖尿病患者中验证。
主要发现
- 糖尿病小鼠较正常血糖小鼠血浆5种miRNA下调,其中miR-409-3p在糖尿病小鼠胰岛免疫浸润中原位也下调。
- 靶点预测工具将miR-409-3p与免疫和代谢相关信号分子关联。
- 原位miR-409-3p表达与胰岛炎严重程度相关,CD8+中枢记忆T细胞中富集miR-409-3p。
- 血浆miR-409-3p水平在糖尿病发展过程中逐渐降低,抗CD3抗体治疗缓解后改善。
- 新诊断1型糖尿病患者血浆miR-409-3p水平低于非糖尿病对照组,且与HbA1c水平呈负相关。
临床怎么用
- miR-409-3p有望作为评估胰岛炎症和1型糖尿病严重程度的循环生物标志物,但尚需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS/HYPOTHESIS: MicroRNAs (miRNAs) are a novel class of potential biomarkers emerging in many diseases, including type 1 diabetes. Here, we aim to analyse a panel of circulating miRNAs in non-obese diabetic (NOD) mice and individuals with type 1 diabetes. METHODS: We adopted standardised methodologies for extracting miRNAs from small sample volumes to evaluate a profiling panel of mature miRNAs in paired plasma and laser-captured microdissected immune-infiltrated islets of recently diabetic and normoglycaemic NOD mice. Moreover, we validated the findings during disease progression and remission after anti-CD3 therapy in NOD mice, as well as in individuals with type 1 diabetes. RESULTS: Plasma levels of five miRNAs were downregulated in diabetic vs normoglycaemic mice. Of those, miR-409-3p was also downregulated in situ in the immune islet infiltrates of diabetic mice, suggesting an association with disease pathogenesis. Target-prediction tools linked miR-409-3p to immune- and metabolism-related signalling molecules. In situ miR-409-3p expression correlated with insulitis severity, and CD8+ central memory T cells were found to be enriched in miR-409-3p. Plasma miR-409-3p levels gradually decreased during diabetes development and improved with disease remission after anti-CD3 antibody therapy. Finally, plasma miR-409-3p levels were lower in people recently diagnosed with type 1 diabetes compared with a non-diabetic control group, and levels were inversely correlated with HbA1c levels. CONCLUSIONS/INTERPRETATION: We propose that miR-409-3p may represent a new circulating biomarker of islet inflammation and type 1 diabetes severity.
引用
- Ventriglia G, Mancarella F, Sebastiani G, et al. miR-409-3p is reduced in plasma and islet immune infiltrates of NOD diabetic mice and is differentially expressed in people with type 1 diabetes. Diabetologia. 2019. PMID: 31659408. doi:10.1007/s00125-019-05026-1
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。